Do you want to read an article? Please log in or register.
Feasibility of deriving a novel imaging biomarker based on patient-specific lung elasticity for characterizing the degree of COPD in lung SBRT patients
COPD
Related content
RECOMMENDED
Lung Cancer
Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer.
Tessema M, Tassew DD, Yingling CM, Do K, Picchi MA, Wu G, Petersen H, Randell S, Lin Y, Belinsky SA, Tesfaigzi Y
doi: 10.1016/j.lungcan.2020.05.017.
COMMENTED
Feasibility, acceptability and effectiveness of integrated care for COPD patients: a mixed methods evaluation of a pilot community-based programme
Swiss Med Wkly.
Carron T, Bridevaux PO, Lörvall K, Parmentier R, Moix JB, Beytrison V, Pernet R, Rey C, Roberfroid PY, Chhajed PN, Dieterle T, Joos Zellweger L, Kohler M, Maier S, Miedinger D, Thurnheer R, Urwyler P, Tschopp JM, Zuercher E, Leuppi JD, Burnand B, Peytremann-Bridevaux I
doi: 10.4414/smw.2017.14567.
RECOMMENDED
COPD
COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging
Eur Respir J.
Washko GR, Parraga G
doi: 10.1183/13993003.
Lung Cancer
Association between age, deprivation and specific comorbid conditions and the receipt of major surgery in patients with non-small cell lung cancer in England: A population-based study
Thorax.
Belot A, Fowler H, Njagi EN, Luque-Fernandez MA, Maringe C, Magadi W, Exarchakou A, Quaresma M, Turculet A, Peake MD, Navani N, Rachet B
doi: 10.1136/thoraxjnl-2017-211395.
RECOMMENDED
COPD
Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS)
Respir Res.
Haghighi B, Choi S, Choi J, Hoffman EA, Comellas AP, Newell JD Jr, Lee CH, Barr RG, Bleecker E, Cooper CB, Couper D, Han ML, Hansel NN, Kanner RE, Kazerooni EA, Kleerup EAC, Martinez FJ, O'Neal W, Paine R 3rd, Rennard SI, Smith BM, Woodruff PG, Lin CL
doi: 10.1186/s12931-
RECOMMENDED
Lung Cancer
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Lancet Oncol.
Nestle U, Schimek-Jasch T, Kremp S, Schaefer-Schuler A, Mix M, Küsters A, Tosch M, Hehr T, Eschmann SM, Bultel YP, Hass P, Fleckenstein J, Thieme A, Stockinger M, Dieckmann K, Miederer M, Holl G, Rischke HC, Gkika E, Adebahr S, König J, Grosu AL, PET-Plan study group
doi: 10.1016/S1470-2045(20)30013-9.
Serum Surfactant Protein D as a Biomarker for Measuring Lung Involvement in Obese Type 2 Diabetic Patients
J Clin Endocrinol Metab.
López-Cano C, Lecube A, García-Ramírez M, Muñoz X, Sánchez E, Seminario A, Hernández M, Ciudin A, Gutiérrez L, Hernández C, Simó R
doi: 10.1210/jc.2017-00913.
COPDLung Cancer
Signal enhancement ratio imaging of the lung parenchyma with ultra-fast steady-state free precession MRI at 1.5T
J Magn Reson Imaging.
Pusterla O, Sommer G, Santini F, Wiese M, Lardinois D, Tamm M, Bremerich J, Bauman G, Bieri O
doi: 10.1002/jmri.25928.
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study
Pulm Pharmacol Ther.
Rogliani P, Ora J, Puxeddu E, Calzetta L, Cavalli F, Matera MG, Cazzola M
doi: 10.1016/j.pupt.2017.12.010.